Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres
- 12 November 2020
- journal article
- research article
- Published by Elsevier BV in Clinical Microbiology & Infection
- Vol. 27 (3), 472.e7-472.e10
- https://doi.org/10.1016/j.cmi.2020.11.004
Abstract
No abstract availableKeywords
Funding Information
- Roche Diagnostics
- bioMerieux Inc.
- Pfizer
- Merck
This publication has 10 references indexed in Scilit:
- Clinical Evaluation of BD Veritor SARS-CoV-2 Point-of-Care Test Performance Compared to PCR-Based Testing and versus the Sofia 2 SARS Antigen Point-of-Care TestJournal of Clinical Microbiology, 2020
- Rethinking Covid-19 Test Sensitivity — A Strategy for ContainmentNew England Journal of Medicine, 2020
- Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptomsJournal of Clinical Virology, 2020
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Upper Respiratory Tract of Children and Adults With Early Acute Coronavirus Disease 2019 (COVID-19)Clinical Infectious Diseases, 2020
- Published by Elsevier BV ,2020
- Culture-Based Virus Isolation To Evaluate Potential Infectivity of Clinical Specimens Tested for COVID-19Journal of Clinical Microbiology, 2020
- Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal SwabsJournal of Clinical Microbiology, 2020
- Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic SamplesClinical Infectious Diseases, 2020
- Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosisJournal of Clinical Virology, 2020
- Virological assessment of hospitalized patients with COVID-2019Nature, 2020